Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $84,118 | 61 | 58.0% |
| Travel and Lodging | $44,249 | 106 | 30.5% |
| Food and Beverage | $14,903 | 507 | 10.3% |
| Consulting Fee | $1,707 | 3 | 1.2% |
| Education | $178.99 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $136,078 | 326 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $931.76 | 1 | $0 (2022) |
| Celgene Corporation | $482.96 | 17 | $0 (2024) |
| BeiGene USA, Inc. | $474.75 | 12 | $0 (2024) |
| GENZYME CORPORATION | $474.38 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $361.18 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $360.51 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $351.30 | 6 | $0 (2022) |
| Genentech USA, Inc. | $324.94 | 14 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $297.56 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,552 | 154 | Incyte Corporation ($10,071) |
| 2023 | $40,084 | 190 | Incyte Corporation ($38,538) |
| 2022 | $53,254 | 163 | Incyte Corporation ($50,675) |
| 2021 | $39,265 | 172 | Incyte Corporation ($36,794) |
All Payment Transactions
679 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Oncology | ||||||
| 12/20/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $9.93 | General |
| Category: Hematology | ||||||
| 12/17/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Rare Disease | ||||||
| 12/13/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 12/09/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Oncology | ||||||
| 12/06/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| 11/12/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $26.91 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/12/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.03 | General |
| 11/08/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Oncology | ||||||
| 10/28/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: ONCOLOGIC AGENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 209 | 352 | $87,370 | $19,331 |
| 2022 | 3 | 212 | 341 | $82,793 | $21,655 |
| 2021 | 4 | 276 | 434 | $81,955 | $24,724 |
| 2020 | 3 | 289 | 487 | $106,385 | $25,300 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 235 | $58,045 | $12,839 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 48 | $17,664 | $4,016 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 69 | $11,661 | $2,475 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 65 | 125 | $39,336 | $10,812 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 149 | $33,278 | $8,303 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 67 | $10,179 | $2,540 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 240 | $48,000 | $14,386 | 30.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 75 | $20,250 | $6,606 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 93 | $11,625 | $3,194 | 27.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 26 | 26 | $2,080 | $538.66 | 25.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 94 | 198 | $53,460 | $13,572 | 25.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 224 | $44,800 | $9,848 | 22.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 65 | $8,125 | $1,881 | 23.2% |
About Dana Delaski, NP-C
Dana Delaski, NP-C is a Family healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1467753772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dana Delaski, NP-C has received a total of $145,155 in payments from pharmaceutical and medical device companies, with $12,552 received in 2024. These payments were reported across 679 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($84,118).
As a Medicare-enrolled provider, Delaski has provided services to 986 Medicare beneficiaries, totaling 1,614 services with total Medicare billing of $91,010. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Jackson, MS
- Active Since 11/03/2010
- Last Updated 04/10/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1467753772
Products in Payments
- JAKAFI (Drug) $68,665
- MONJUVI (Drug) $67,377
- BRUKINSA (Drug) $458.20
- SARCLISA (Biological) $368.92
- REBLOZYL (Biological) $350.65
- IMBRUVICA (Drug) $281.93
- VENCLEXTA (Biological) $244.58
- SOMATULINE DEPOT (Drug) $230.69
- MONOFERRIC (Drug) $228.03
- CALQUENCE (Drug) $214.56
- ICLUSIG (Drug) $207.28
- KEYTRUDA (Biological) $190.47
- Endari (Drug) $177.22
- ADCETRIS (Biological) $157.69
- Pomalyst (Drug) $148.54
- Venclexta (Biological) $142.64
- Yescarta (Drug) $131.64
- AYVAKIT (Drug) $128.07
- EPKINLY (Drug) $125.82
- ONUREG (Drug) $125.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Jackson
Gina Burge, Np, NP
Family — Payments: $182,303
Anahita Anderson, Fnp, FNP
Family — Payments: $51,628
Leondrea Stewart Collins, Fnp-C, FNP-C
Family — Payments: $14,319
Anna Walley, Fnp, FNP
Family — Payments: $13,785
Teresa Spencer, Cfnp, CFNP
Family — Payments: $12,519
Mrs. Catherine Page, Fnp, FNP
Family — Payments: $11,925